Ing Soo Tiong (Ing S Tiong)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 27

Top Topics

Ulcerative Colitis

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

British journal of haematology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Carlos Jimenez Chillon, Jad Othman, David Taussig, Carlos Jiménez-Vicente, Alexandra Martínez-Roca, Ing Soo Tiong, Manish Jain, James Aries, Seda Cakmak, Stephen Knapper, Daniel Tuyet Kristensen, Vidhya Murthy, Zacharoula Galani, Charlotte Kallmeyer, Loretta Ngu, David Veale, Simon Bolam, Nina Orfali, Anne Parker, Cara Manson, Jane Parker, Thomas Erblich, Deborah Susan Richardson, Katya Mokretar, Nicola Potter, Ulrik Malthe Overgaard, Anne Stidsholt Roug, Andrew H Wei, Jordi Esteve, Martin Jädersten, Nigel H Russell, Richard Dilon
Venetoclax-based low intensity therapy in molecular failure of NPM1 mutated AML. Blood advances (2023)
Ing Soo Tiong, Sun Loo
Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication. International journal of molecular sciences 24 (5) (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Melissa Ng Liet Hing, Georgina L Ryland, Tamia Nguyen, Ing Soo Tiong, Karen Dun, Slavisa Ninkovic, Rithin Nedumannil, David A Westerman, Piers A Blombery, Kah Lok Chan, Ashish Bajel
Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity. British journal of haematology (2023)
Ing Soo Tiong, Sun Loo
Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication. International journal of molecular sciences 24 (5) (2023)
Sun Loo, Andrew W Roberts, Natasha S Anstee, Glen A Kennedy, Simon Zhao-Xiong He, Anthony P Schwarer, Anoop Kumar Enjeti, James D'Rozario, Paula Marlton, Ian Bilmon, John M Taper, Gavin Cull, Campbell Tiley, Emma Verner, Uwe Hahn, Devendra K Hiwase, Harry J Iland, Nicholas Edward Murphy, Sundra Ramanathan, John Reynolds, Doen Ming Ong, Ing Soo Tiong, Meaghan Wall, Michael Murray, Tristan Rawling, Joanna Leadbetter, Leesa Rowley, Maya Latimer, Sam L S Yuen, Stephen B Ting, Chun Yew Fong, Kirk Lachlan Morris, Ashish Bajel, John Francis Seymour, Mark J Levis, Andrew H Wei
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML:a randomized, placebo-controlled study by the ALLG. Blood (2023)
Ing Soo Tiong, Sun Loo
Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication. International journal of molecular sciences 24 (5) (2023)
Jad Othman, Ing Soo Tiong, Jenny O'Nions, Mike Dennis, Katya Mokretar, Adam Ivey, Michael James Austin, Annie-Louise Latif, Mariam Amer, Wei Yee Chan, Charles R Crawley, Francesca Crolla, Joe Wilson Cross, Raymond Dang, Johnathon Elliot, Chun Yew Fong, Sofia Galli, Paolo Gallipoli, Francesca Hogan, Pallavi Kalkur, Anjum Bashir Khan, Pramila Krishnamurthy, John Laurie, Sun Loo, Scott Marshall, Priyanka Mehta, Vidhya Murthy, Sateesh Nagumantry, Srinivas Pillai, Nicola Potter, Rob S Sellar, Thomas Taylor, Rui Zhao, Nigel H Russell, Andrew H Wei, Richard Dilon
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based non-intensive therapy. Blood (2023)
Ing Soo Tiong, William S Stevenson, Meaghan Wall, Yan Zhuang Yap, John F Seymour, Melita Kenealy, Piers A Blombery, null null
Favorable outcomes of DDX41 -mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide. EJHaem 4 (4) (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung H Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood 141 (9) (2023)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty M Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika M Kutyna, Hassan B Alkhateeb, Talha Badar, Paul Po-Shen Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter G Bardy, Ashanka Beligaswatte, David T Yeung, Mark R Litzow, Abhishek A Mangaonkar, Pratyush Giri, Cindy H Lee, Angelina Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William J Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung Hoow Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood (2022)
Phillip Cuong Nguyen, Ing Soo Tiong, David A Westerman, Piers A Blombery
A novel ATRX variant with splicing consequences in myelodysplastic syndrome with acquired alpha thalassaemia. British journal of haematology (2022)
Devendra K Hiwase, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref A Al-Kali, Kirsty M Sharplin, Dariusz Ladon, Rachel Hollins, Patricia T Greipp, Monika M Kutyna, Hassan B Alkhateeb, Talha Badar, Paul Po-Shen Wang, David Morrall Ross, Deepak Singhal, Naranie Shanmuganathan, Peter G Bardy, Ashanka Beligaswatte, David T Yeung, Mark R Litzow, Abhishek A Mangaonkar, Pratyush Giri, Cindy H Lee, Angelina Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William J Hogan, Naseema Gangat, Mirinal S Patnaik, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Sharad Kumar, Anna L Brown, Hamish S Scott, Daniel Thomas, Chung Hoow Kok, Ayalew Tefferi, Mithun Vinod Shah
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype. Blood (2022)
Donia M Moujalled, Fiona C Brown, Chong Chyn Chua, Michael A Dengler, Giovanna Pomilio, Natasha S Anstee, Veronique Litalien, Ella R Thompson, Thomas David Morley, Sarah MacRaild, Ing Soo Tiong, Rhiannon Morris, Karen Dun, Adrian Carl Zordan, Jaynish S Shah, Sébastien Banquet, Ensar Halilovic, Erick J Morris, Marco J Herold, Guillaume L Lessene, Jerry M Adams, David Ching Siang Huang, Andrew W Roberts, Piers Blombery, Andrew H Wei
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in Acute Myeloid Leukemia. Blood (2022)
Sun Loo, Richard Dillon, Adam Ivey, Natasha S Anstee, Jad Othman, Ing Soo Tiong, Nicola Potter, Jelena Jovanovic, Manohursingh Runglall, Chyn Chua Chong, Ashish Bajel, David Ritchie, Kelli Gray, Zhi Han Yeoh, Michelle McBean, Amanda Gilkes, Ian Thomas, Sean J Johnson, Nigel H Russell, Andrew H Wei
Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome. Blood 140 (22) (2022)
Ing Soo Tiong, Richard Dilon, Adam Ivey, James A Kuzich, Nisha Thiagarajah, Kirsty M Sharplin, Chung Hoow Kok, Aditya Tedjaseputra, James P Rowland, Carolyn S Grove, Emad Abro, Jake Shortt, Devendra K Hiwase, Ashish Bajel, Nicola E Potter, Matthew L Smith, Claire J Hemmaway, Abin Thomas, Amanda F Gilkes, Nigel H Russell, Andrew H Wei
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia. Blood advances 5 (23) (2022)
Georgina L Ryland, Masayuki Umeda, Linda Holmfeldt, Sören Lehmann, Morten Krogh Krogh Herlin, Jing J Ma, Mahsa Khanlari, Jeffrey E Rubnitz, Rhonda E Ries, Hansen J Kosasih, Paul G Ekert, Hwee Ngee Goh, Ing Soo Tiong, Sean M Grimmond, Claudia Haferlach, Ryan B Day, Timothy J Ley, Soheil Meshinchi, Xiaotu Ma, Piers Blombery, Jeffery M Klco
Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertions. Blood (2022)
Mithun Vinod Shah, Rakchha Chhetri, Ruchita Dholakia, Chung Hoow Kok, Naseema Gangat, Hassan B Alkhateeb, Aref Al-Kali, Mirinal S Patnaik, Anmol Baranwal, Patricia T Greipp, Rong He, Kebede H Begna, Ing Soo Tiong, Andrew H Wei, Devendra K Hiwase
Outcomes following venetoclax-based treatment in therapy-related myeloid neoplasms. American journal of hematology 97 (8) (2022)
Phillip C Nguyen, Kate Manos, Chun Yew Fong, Anthony P Schwarer, Ing Soo Tiong, Andrew H Wei, David S Kliman, David J Curtis
Outcomes of non-myeloablative allogeneic stem cell transplant in older patients with acute myeloid leukaemia in first remission. Internal medicine journal 51 (11) (2021)
Claudie Bosc, Estelle Saland, Aurélie Bousard, Noémie Gadaud, Marie Sabatier, Guillaume Cognet, Thomas Farge, Emeline Boet, Mathilde Gotanègre, Nesrine Aroua, Pierre-Luc Mouchel, Nathaniel Polley, Clément Larrue, Eléonore Kaphan, Muriel Picard, Ambrine Sahal, Latifa Jarrou, Marie Tosolini, Florian Rambow, Florence Cabon, Nathalie Nicot, Laura Poillet-Perez, Yujue Wang, Xiaoyang Su, Quentin Fovez, Jérôme Kluza, Rafael Jose Argüello, Céline Mazzotti, Hervé Avet-Loiseau, François Vergez, Jérôme Tamburini, Jean-Jacques Fournié, Ing Soo Tiong, Andrew H Wei, Tony Kaoma, Jean-Christophe Marine, Christian Recher, Lucille Stuani, Carine Joffre, Jean-Emmanuel Sarry
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia. Nature cancer 2 (11) (2021)
Chong Chyn Chua, Andrew W Roberts, John Reynolds, Chun Yew Fong, Stephen B Ting, Jessica M Salmon, Sarah MacRaild, Adam Ivey, Ing Soo Tiong, Shaun Fleming, Fiona C Brown, Sun Loo, Ian J Majewski, Stefan K Bohlander, Andrew H Wei
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (30) (2020)
Ing Soo Tiong, Richard Dilon, Adam Ivey, Tse-Chieh Teh, Phillip Nguyen, Nicholas Cummings, David C Taussig, Annie-Louise Latif, Nicola E Potter, Manohursingh Runglall, Nigel H Russell, Kavita Raj, Anthony P Schwarer, Chun Yew Fong, Andrew P Grigg, Andrew H Wei
Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemia. British journal of haematology 192 (6) (2020)
Ing Soo Tiong, Andrew H Wei
New drugs creating new challenges in acute myeloid leukemia. Genes, chromosomes & cancer 58 (12) (2019)
Ing Soo Tiong, John Reynolds, Kenneth F Bradstock, John F Seymour, Andrew H Wei, null null
Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies. Blood cancer journal 8 (9) (2018)
Andrew H Wei, Ing Soo Tiong
Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML. Blood 130 (23) (2017)
Ing Soo Tiong, Peter Tan, Julie McManus, Nik Cummings, Sonali Sadawarte, John Catalano, Robert Hills, Andrew H Wei
Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia. Leukemia & lymphoma 59 (2) (2017)